BR100 Increased By (0.08%)
BR30 Decreased By (-0.04%)
KSE100 Increased By (0.34%)
KSE30 Increased By (0.2%)
AGHA 7.68 Increased By ▲ 0.05 (0.66%)
BECO 5.45 Decreased By ▼ -0.12 (-2.15%)
BML 59.92 Increased By ▲ 0.18 (0.3%)
BOP 34.83 Increased By ▲ 0.43 (1.25%)
CNERGY 12.88 Decreased By ▼ -0.23 (-1.75%)
CSIL 6.49 Increased By ▲ 0.08 (1.25%)
FCCL 57.79 Decreased By ▼ -0.27 (-0.47%)
FFL 16.33 Increased By ▲ 0.10 (0.62%)
FNEL 1.21 No Change ▼ 0.00 (0%)
KEL 7.45 Increased By ▲ 0.02 (0.27%)
KOSM 6.10 Increased By ▲ 0.07 (1.16%)
LOTCHEM 27.75 Increased By ▲ 0.08 (0.29%)
MLCF 102.56 Decreased By ▼ -0.19 (-0.18%)
NBP 205.54 Increased By ▲ 0.48 (0.23%)
NCPL 61.26 Increased By ▲ 1.63 (2.73%)
NPL 69.85 Increased By ▲ 1.29 (1.88%)
OGDC 319.75 Increased By ▲ 0.83 (0.26%)
PACE 11.18 Increased By ▲ 0.13 (1.18%)
PAEL 43.00 Decreased By ▼ -0.10 (-0.23%)
PIBTL 16.68 Increased By ▲ 0.05 (0.3%)
PPL 229.40 Decreased By ▼ -0.05 (-0.02%)
PRL 70.20 Decreased By ▼ -0.60 (-0.85%)
PTC 71.10 Increased By ▲ 0.10 (0.14%)
SSGC 27.60 Increased By ▲ 0.19 (0.69%)
TBL 10.35 Increased By ▲ 0.04 (0.39%)
TELE 8.60 Increased By ▲ 0.07 (0.82%)
TPL 23.13 Increased By ▲ 0.07 (0.3%)
TPLP 15.89 Increased By ▲ 0.13 (0.82%)
TREET 25.04 Increased By ▲ 0.33 (1.34%)
TRG 60.15 Decreased By ▼ -0.14 (-0.23%)
By

LONDON: The world's first human challenge trial in which volunteers were deliberately exposed to COVID-19 to advance research into the disease was found to be safe in healthy young adults, one of the companies running the study said on Wednesday.

The data supports the safety of this model which could theoretically provide a "plug and play" platform for testing therapies and vaccines using the original COVID-19 strain as well as variants of the virus, Open Orphan, which carried out the study, said in a statement.

Omicron sub-variant found in 57 countries: WHO

Open Orphan is running the project, launched a year ago, with Imperial College London, the UK government's vaccines task force and the clinical company hVIVO.

Comments

Comments are closed for this article.